vs
Side-by-side financial comparison of Burke & Herbert Financial Services Corp. (BHRB) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
Burke & Herbert Financial Services Corp. is the larger business by last-quarter revenue ($86.5M vs $47.7M, roughly 1.8× IRONWOOD PHARMACEUTICALS INC). Burke & Herbert Financial Services Corp. runs the higher net margin — 34.9% vs -4.8%, a 39.7% gap on every dollar of revenue. On growth, Burke & Herbert Financial Services Corp. posted the faster year-over-year revenue change (4.9% vs -47.3%). Burke & Herbert Financial Services Corp. produced more free cash flow last quarter ($96.2M vs $74.6M). Over the past eight quarters, Burke & Herbert Financial Services Corp.'s revenue compounded faster (81.1% CAGR vs -20.2%).
Burke & Herbert Financial Services Corp is a U.S.-based regional financial holding company, offering personal and commercial banking, wealth management, residential mortgage lending, and small business financing services. Its core market covers Virginia and adjacent Mid-Atlantic regions, serving retail consumers, SMEs, and high-net-worth clients.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
BHRB vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.5M | $47.7M |
| Net Profit | $30.2M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | 43.8% | 14.3% |
| Net Margin | 34.9% | -4.8% |
| Revenue YoY | 4.9% | -47.3% |
| Net Profit YoY | 52.8% | -200.9% |
| EPS (diluted) | $1.98 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.5M | $47.7M | ||
| Q3 25 | $85.4M | $122.1M | ||
| Q2 25 | $87.1M | $85.2M | ||
| Q1 25 | $83.0M | $41.1M | ||
| Q4 24 | $82.5M | $90.5M | ||
| Q3 24 | $83.8M | $91.6M | ||
| Q2 24 | $69.3M | $94.4M | ||
| Q1 24 | $26.4M | $74.9M |
| Q4 25 | $30.2M | $-2.3M | ||
| Q3 25 | $30.0M | $40.1M | ||
| Q2 25 | $29.9M | $23.6M | ||
| Q1 25 | $27.2M | $-37.4M | ||
| Q4 24 | $19.8M | $2.3M | ||
| Q3 24 | $27.6M | $3.6M | ||
| Q2 24 | $-16.9M | $-860.0K | ||
| Q1 24 | $5.2M | $-4.2M |
| Q4 25 | 43.8% | 14.3% | ||
| Q3 25 | 43.3% | 61.8% | ||
| Q2 25 | 42.7% | 53.2% | ||
| Q1 25 | 39.6% | -70.7% | ||
| Q4 24 | 24.6% | 34.8% | ||
| Q3 24 | 39.2% | 28.0% | ||
| Q2 24 | -27.5% | 26.5% | ||
| Q1 24 | 22.3% | 14.7% |
| Q4 25 | 34.9% | -4.8% | ||
| Q3 25 | 35.1% | 32.8% | ||
| Q2 25 | 34.3% | 27.7% | ||
| Q1 25 | 32.8% | -90.9% | ||
| Q4 24 | 24.0% | 2.5% | ||
| Q3 24 | 33.0% | 4.0% | ||
| Q2 24 | -24.4% | -0.9% | ||
| Q1 24 | 19.8% | -5.6% |
| Q4 25 | $1.98 | $0.01 | ||
| Q3 25 | $1.97 | $0.23 | ||
| Q2 25 | $1.97 | $0.14 | ||
| Q1 25 | $1.80 | $-0.23 | ||
| Q4 24 | $1.72 | $0.03 | ||
| Q3 24 | $1.82 | $0.02 | ||
| Q2 24 | $-1.41 | $-0.01 | ||
| Q1 24 | $0.69 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $854.6M | $-261.8M |
| Total Assets | $7.9B | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | — | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | — | $88.6M | ||
| Q3 24 | — | $88.2M | ||
| Q2 24 | — | $105.5M | ||
| Q1 24 | — | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $854.6M | $-261.8M | ||
| Q3 25 | $822.2M | $-264.2M | ||
| Q2 25 | $780.0M | $-308.2M | ||
| Q1 25 | $758.0M | $-334.1M | ||
| Q4 24 | $730.2M | $-301.3M | ||
| Q3 24 | $738.1M | $-311.3M | ||
| Q2 24 | $693.1M | $-321.7M | ||
| Q1 24 | $319.3M | $-330.5M |
| Q4 25 | $7.9B | $396.9M | ||
| Q3 25 | $7.9B | $396.1M | ||
| Q2 25 | $8.1B | $342.9M | ||
| Q1 25 | $7.8B | $327.2M | ||
| Q4 24 | $7.8B | $350.9M | ||
| Q3 24 | $7.9B | $389.5M | ||
| Q2 24 | $7.8B | $395.6M | ||
| Q1 24 | $3.7B | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $107.9M | $74.6M |
| Free Cash FlowOCF − Capex | $96.2M | $74.6M |
| FCF MarginFCF / Revenue | 111.2% | 156.3% |
| Capex IntensityCapex / Revenue | 13.5% | 0.0% |
| Cash ConversionOCF / Net Profit | 3.57× | — |
| TTM Free Cash FlowTrailing 4 quarters | $164.1M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $107.9M | $74.6M | ||
| Q3 25 | $39.3M | $47.6M | ||
| Q2 25 | $41.0K | $-15.1M | ||
| Q1 25 | $37.6M | $20.0M | ||
| Q4 24 | $85.8M | $15.2M | ||
| Q3 24 | $47.8M | $9.9M | ||
| Q2 24 | $-46.0M | $33.5M | ||
| Q1 24 | $7.1M | $45.0M |
| Q4 25 | $96.2M | $74.6M | ||
| Q3 25 | $35.4M | $47.6M | ||
| Q2 25 | $-3.4M | $-15.1M | ||
| Q1 25 | $35.9M | $19.9M | ||
| Q4 24 | $81.2M | — | ||
| Q3 24 | $46.0M | $9.9M | ||
| Q2 24 | $-47.0M | $33.4M | ||
| Q1 24 | $5.6M | $44.9M |
| Q4 25 | 111.2% | 156.3% | ||
| Q3 25 | 41.5% | 39.0% | ||
| Q2 25 | -3.9% | -17.7% | ||
| Q1 25 | 43.2% | 48.4% | ||
| Q4 24 | 98.5% | — | ||
| Q3 24 | 55.0% | 10.8% | ||
| Q2 24 | -67.8% | 35.4% | ||
| Q1 24 | 21.2% | 60.0% |
| Q4 25 | 13.5% | 0.0% | ||
| Q3 25 | 4.5% | 0.0% | ||
| Q2 25 | 3.9% | 0.0% | ||
| Q1 25 | 2.1% | 0.1% | ||
| Q4 24 | 5.5% | 0.0% | ||
| Q3 24 | 2.1% | 0.0% | ||
| Q2 24 | 1.5% | 0.1% | ||
| Q1 24 | 5.7% | 0.1% |
| Q4 25 | 3.57× | — | ||
| Q3 25 | 1.31× | 1.19× | ||
| Q2 25 | 0.00× | -0.64× | ||
| Q1 25 | 1.38× | — | ||
| Q4 24 | 4.33× | 6.74× | ||
| Q3 24 | 1.73× | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
